JP2024506228A5 - - Google Patents
Info
- Publication number
- JP2024506228A5 JP2024506228A5 JP2023517276A JP2023517276A JP2024506228A5 JP 2024506228 A5 JP2024506228 A5 JP 2024506228A5 JP 2023517276 A JP2023517276 A JP 2023517276A JP 2023517276 A JP2023517276 A JP 2023517276A JP 2024506228 A5 JP2024506228 A5 JP 2024506228A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- pharmaceutical composition
- composition according
- polysorbate
- glycerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063079195P | 2020-09-16 | 2020-09-16 | |
| PCT/IB2021/000640 WO2022058795A1 (en) | 2020-09-16 | 2021-09-15 | Compositions and methods for the treatment of lipid-related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506228A JP2024506228A (ja) | 2024-02-13 |
| JP2024506228A5 true JP2024506228A5 (cg-RX-API-DMAC7.html) | 2024-09-25 |
Family
ID=80776673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517276A Pending JP2024506228A (ja) | 2020-09-16 | 2021-09-15 | 脂質関連障害の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230355584A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4213835A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024506228A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116685316A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021344871A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301325A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022058795A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016203468A1 (en) | 2015-06-15 | 2016-12-22 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013072915A1 (en) * | 2011-11-15 | 2013-05-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Tricyclic compounds, compositions comprising them and uses thereof |
| WO2016020919A1 (en) * | 2014-08-07 | 2016-02-11 | Raziel Therapeutics Ltd. | Compositions comprising tricyclic compounds, and uses thereof |
-
2021
- 2021-09-15 EP EP21868804.2A patent/EP4213835A4/en active Pending
- 2021-09-15 IL IL301325A patent/IL301325A/en unknown
- 2021-09-15 WO PCT/IB2021/000640 patent/WO2022058795A1/en not_active Ceased
- 2021-09-15 US US18/245,132 patent/US20230355584A1/en active Pending
- 2021-09-15 JP JP2023517276A patent/JP2024506228A/ja active Pending
- 2021-09-15 CN CN202180077281.9A patent/CN116685316A/zh active Pending
- 2021-09-15 AU AU2021344871A patent/AU2021344871A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021185179A (ja) | 固溶体組成物および心血管疾患における使用 | |
| US10857118B2 (en) | Compositions and methods for treating intestinal hyperpermeability | |
| US11197852B2 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| EP3238707B1 (en) | Compositions and methods for treating intestinal hyperpermeability | |
| US20220000824A1 (en) | Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid | |
| RU2011149976A (ru) | Композиции для непрерывного управления ингибиторами допа-декарбоксилазы | |
| JP2014507429A (ja) | 心血管疾患の治療のための組成物および方法 | |
| RU2017112149A (ru) | Комбинация омега-3 жирной кислоты и SGLT-2 ингибитора для лечения болезней печени | |
| CN111214464A (zh) | 包含15-hepe的组合物以及其使用方法 | |
| JP2020063259A (ja) | 15−hepeを含む組成物及びその使用方法 | |
| RU2017112308A (ru) | Композиции и способы для лечения бессонницы | |
| KR102437682B1 (ko) | 특화된 사전 해소 매개체의 염에 관한 조성물 및 방법 | |
| CN108884053A (zh) | 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法 | |
| JPWO2013031729A1 (ja) | 糖尿病性心血管合併症の予防・治療剤 | |
| JP6542006B2 (ja) | 外用医薬組成物 | |
| CN112245419A (zh) | 包括15-hepe的组合物以及使用其治疗或预防纤维化的方法 | |
| RU2014129437A (ru) | Офтальмологическая композиция | |
| WO2016020919A1 (en) | Compositions comprising tricyclic compounds, and uses thereof | |
| TW201328727A (zh) | 具改良穩定性之包含ω-3脂肪酸及HMG-CoA還原酶抑制劑的口服複合調配物 | |
| KR20100041891A (ko) | 간염세포 및/또는 간경변 세포의 형질전환을 억제하는 간암 예방제 | |
| JP2018510206A5 (cg-RX-API-DMAC7.html) | ||
| US20240424016A1 (en) | Buffering for non-alcoholic steatohepatitis and liver diseases | |
| CN114945374A (zh) | 药物组合物和方法 | |
| JP2023531918A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2018016596A1 (ja) | PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤 |